John Stuart Patton is Director at HALOZYME THERAPEUTICS INC (HALO). They have made 6 open-market trades across 2 companies since 2006, most recently 2014-08-19.
CIK 0001247653
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HALO | SELL | 2014-08-19 | 2014-08-21 | $9.96 | $747K | -40.6% | -1.7% | -1.7% |
| HALO | SELL | 2013-09-13 | 2013-09-16 | $9.13 | $685K | -40.6% | -1.7% | -1.7% |
| NKTR | SELL | 2008-11-14 | 2008-11-18 | $4.37 | $3K | -19.7% | -1.3% | -1.3% |
| HALO | SELL · 10b5-1 | 2007-10-16 | 2007-10-18 | $9.04 | $136K | -40.6% | -1.7% | -1.7% |
| HALO | SELL · 10b5-1 | 2007-10-09 | 2007-10-11 | $8.69 | $130K | -40.6% | -1.7% | -1.7% |
| HALO | SELL · 10b5-1 | 2007-10-02 | 2007-10-02 | $8.90 | $133K | -40.6% | -1.7% | -1.7% |
| HALO | SELL · 10b5-1 | 2007-09-25 | 2007-09-26 | $8.94 | $134K | -40.6% | -1.7% | -1.7% |
| HALO | SELL · 10b5-1 | 2007-09-18 | 2007-09-19 | $8.93 | $156K | -40.6% | -1.7% | -1.7% |
| HALO | SELL · 10b5-1 | 2007-07-10 | 2007-07-11 | $9.78 | $196K | -40.6% | -1.7% | -1.7% |
| HALO | SELL · 10b5-1 | 2007-06-26 | 2007-06-26 | $8.98 | $74K | -40.6% | -1.7% | -1.7% |
| HALO | SELL · 10b5-1 | 2007-06-26 | 2007-06-26 | $8.66 | $102K | -40.6% | -1.7% | -1.7% |
| HALO | SELL · 10b5-1 | 2007-06-19 | 2007-06-19 | $10.25 | $205K | -40.6% | -1.7% | -1.7% |
| HALO | SELL · 10b5-1 | 2007-06-12 | 2007-06-14 | $10.05 | $201K | -40.6% | -1.7% | -1.7% |
| HALO | SELL · 10b5-1 | 2007-05-29 | 2007-05-30 | $10.27 | $203K | -40.6% | -1.7% | -1.7% |
| HALO | SELL | 2007-05-23 | 2007-05-23 | $10.50 | $158K | -40.6% | -1.7% | -1.7% |
| HALO | SELL · 10b5-1 | 2007-05-22 | 2007-05-23 | $10.56 | $211K | -40.6% | -1.7% | -1.7% |
| HTI | SELL · 10b5-1 | 2007-04-18 | 2007-04-19 | $9.13 | $228K | N/A | N/A | N/A |
| HTI | SELL · 10b5-1 | 2007-04-11 | 2007-04-12 | $8.62 | $215K | N/A | N/A | N/A |
| HTI | SELL · 10b5-1 | 2007-04-04 | 2007-04-05 | $8.36 | $209K | N/A | N/A | N/A |
| HTI | SELL · 10b5-1 | 2007-03-28 | 2007-03-28 | $8.40 | $210K | N/A | N/A | N/A |
| HTI | SELL · 10b5-1 | 2007-03-21 | 2007-03-21 | $8.59 | $215K | N/A | N/A | N/A |
| HTI | SELL · 10b5-1 | 2007-03-14 | 2007-03-16 | $8.01 | $200K | N/A | N/A | N/A |
| NKTR | SELL | 2006-05-15 | 2006-05-18 | $20.21 | $33K | -19.7% | -1.3% | -1.3% |
| NKTR | SELL | 2006-03-07 | 2006-03-07 | $19.80 | $76K | -19.7% | -1.3% | -1.3% |
| NKTR | SELL · 10b5-1 | 2006-01-27 | 2006-01-30 | $22.00 | $440K | -19.7% | -1.3% | -1.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.